George Clinical – CRO Malaysia

George Clinical In Malaysia

Malaysia is George Clinical’s Southeast Asian hub, where we cover neighboring countries of Singapore, Indonesia and the Philippines – accessing a population of almost 400 million multi-ethnic people.

Singapore is a recognized destination for clinical trials, yet other countries are fast emerging as more governments commit to streamlining their clinical research industry. Malaysia implements a universal healthcare system that co-exists with a private healthcare system. Malaysia has a multi-ethnic population of over 30 million, with moderate life expectancy and infant mortality rate. The government has committed funding to improve the healthcare systems in order to support medical tourism and clinical research. The network of Clinical Research Centres, as well as Clinical Research Malaysia, is part of the government effort to improve the country’s infrastructure to support the industry. To date, Malaysia has 90 industry-sponsored research (ISR) trial sites which are approved by the Ministry of Health (MOH) and local IRBs/ IECs, consisting of 11 prime sites network. They are a mixture of public, teaching and private hospitals, and have participated in over 1,000 ISR trials that require ICH GCP compliance.

Why is the country attractive for sponsors to conduct clinical trials?

The current Malaysian Economic Transformation Program (ETP) targets clinical research as one of its main drivers in economic growth. Therefore, the government of Malaysia established Clinical Research Malaysia (CRM) with the aim of promoting an increase in the number of clinical trials in Malaysia.
CRM supports the clinical research industry to effectively increase the speed, reliability, and delivery of outcomes for all stakeholders involved.
Malaysia has inherent benefits to conduct clinical trials such as its large multi-ethnic population that offers genetic diversity
Established and good public and private healthcare systems
A consistently increasing number of Good Clinical Practice (GCP) trained and compliant investigators and support staff
An established and comprehensive ethical review process by ethics committees
Adherence to intellectual property rights (IPRs) and competitive trial costs compared to other Asian countries.
Malaysia also boasts shorter regulatory and ethics approval timelines for ISR that are comparable with countries like Hong Kong, Japan, Singapore, Taiwan and South Korea
Malaysia ranks high globally with one of the best start-up timelines

Why is George Clinical the CRO of choice for our sponsors in Malaysia?

Established in-country network
Experienced staff on local regulations and requirement
Engagement with key opinion leaders (KOLs) across various therapeutic areas

Contact

Address:
Unit 902, Level 9, Uptown 2 No. 2 Damansara Uptown, Jalan SS 21/37, Damansara Utama 47400 Petaling Jaya, Selangor Malaysia

Email: [email protected]

Details

Population	32.07 million, multi-ethnic
Official Language	Bahasa Malaysia (official), English, Chinese (Cantonese, Mandarin, Hokkien, Hakka, Hainan, Foochow), Tamil, Telugu, Malayalam, Panjabi, Thai
Hospital Records Language	Mostly English
Electronic Hospital Records	Available in selected number of public, teaching and private hospitals only
Site Network	90 hospitals sites, mixture of public, teaching hospital and private
In-country services	Clinical Operations Regulatory Services